Follow the Comera Life Sciences Holdings, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €3k. The latest transaction was disclosed on 28 November 2023 (Acquisition). Among the most active insiders: Cherington Charles. All data is free.
31
Insider Decl.
n/a
Thresholds
€12,108
23 ops.
Buy Volume
n/a
n/a
Sell Volume
23Σ signal
Buys €12,108n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
4,253 shares@ €1.64510.3% of flowCommon StockSEC:0001062993-22-020905:0
Canonical exit: 12 Jan 2023 (T+90)
25 of 31 declarations
About Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. is a company focused on developing biopharmaceutical solutions. It aims to enhance treatments through innovative technologies.